Karen Kelly

American Cancer Society — United States

Medicine · Health Sciences

70h-index21.2kcitations693works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(350), Lung Cancer Research Studies(159), Lung Cancer Diagnosis and Treatment(131), Cancer Immunotherapy and Biomarkers(124), Cancer Genomics and Diagnostics(80)

Publications691 total

A phase 1 study of orally administered 5-fluoro-2’-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors
Cancer Chemotherapy and Pharmacology·2025Open Access
Less Versus More Intensive Surveillance of Pulmonary Nodules Detected Incidentally or by Screening: A Survey of Radiologist Beliefs About Guidelines Implemented in the Watch the Spot Trial
Journal of the American College of Radiology·2025· 1 cited
Radiation Dose Associated With CT in the Watch the Spot Trial: A Pragmatic Trial of Less Versus More Intensive Strategies for Active Follow-Up of Patients With Small Pulmonary Nodules
Journal of the American College of Radiology·2025· 1 cited
Supplementary Table S1 from Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
2025Open Access
Supplementary Figure S1 from Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
2025Open Access
Supplementary Table S3 from Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
2025Open Access
Supplementary Table S2 from Phase II Study of Docetaxel and Trametinib in Patients with <i>KRAS</i> Mutation Positive Recurrent Non–Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042)
2025Open Access
Beyond the trial: Real-world insights into fracture risk among patients with advanced prostate cancer
Journal of Geriatric Oncology·2025
PT2.17.04 First Assessment of IASLC Inclusive Practices and Challenges: Results From the Diversity, Equity, and Inclusion Survey
Journal of Thoracic Oncology·2025
San Diego Sunshine Improves But Does Not Correct Low Vitamin D Levels In Military Recruits
Medicine & Science in Sports & Exercise·2025
The IASLC–Lancet Commission: a transformative global approach to lung cancer
The Lancet·2025
PP01.01: The 2024 International Association for the Study of Lung Cancer (IASLC) Global Survey on Biomarker Testing: Results from Latin America
Journal of Thoracic Oncology·2025
The 2024 International Association for the Study of Lung Cancer Global Survey on Biomarker Testing
Journal of Thoracic Oncology·2025· 4 cited
Elevated ctDNA Tumor Fraction Is Associated with Improved Mutation Detection but Worse Overall Survival in Advanced Non–Small Cell Lung Cancer: A Lung-MAP Study
Clinical Cancer Research·2025Open Access
Biomarker testing of lung cancer in North America versus globally.
Journal of Clinical Oncology·2025· 1 cited
SWOG/NRG S1914: Randomized phase III trial of induction/consolidation atezolizumab + SBRT versus SBRT alone in high risk, early-stage NSCLC.
Journal of Clinical Oncology·2025· 10 cited
S1900E: A phase II study examining impact of co-mutations on sotorasib for previously treated stage IV/recurrent <i>KRAS</i> G12C mutated (MUT) non-squamous (Non-sq) non-small cell lung cancer (NSCLC) (ECOG-ACRIN led Lung-MAP Sub-study).
Journal of Clinical Oncology·2025
Baseline Characteristics of Participants and Pulmonary Nodules in the Watch the Spot Trial: A Pragmatic Trial of Less versus More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
Clinical Lung Cancer·2025· 1 cited
Cancer Outcomes in the Watch the Spot Trial: A Pragmatic Clinical Trial of Less Compared to More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
American Journal of Respiratory and Critical Care Medicine·2025
Cancer Outcomes in the Watch the Spot Trial: A Pragmatic Clinical Trial of Less Compared With More Intensive Strategies for Active Surveillance of Patients With Small Pulmonary Nodules
American Journal of Respiratory and Critical Care Medicine·2025
page 1 of 35Next →

Frequent Co-authors

David R. Gandara(13), Roy S. Herbst(8), Paul A. Bunn(8), James L. Gulley(7), Manish R. Patel(5), Kevin M. Chin(5), Anja von Heydebreck(5), Fred R. Hirsch(5), Mary W. Redman(5), Primo N. Lara(4), Matthew H. Taylor(4), Katherine Minichiello(4), Vassiliki A. Papadimitrakopoulou(4), Philip C. Mack(4), Glen J. Weiss(4), Mark G. Kris(3), Joan H. Schiller(3), Kathy S. Albain(3), John Crowley(3), Geoffrey R. Weiss(3)